A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations
Soo Aleman·Matti Sällberg·Sophia Hober·Lars Frelin·Hanna Tegel·Sofia Appelberg·Simona Salati·Urban Höglund·Ola Tuvesson·Olivia Larsson·Friedemann Weber·A Alisjahbana·Peter N. Bergman·Ali Mirazimi·Marcus Buggert·Eva-Karin Gidlund·Christian An Binh Nordentoft·Katja Tobin·Per Ljungman·Matteo Cadossi·Jingyi Yan·Gustaf Ahlén